25 September 2026 · Medical Device Network
Revvity launches kit targeting early type 1 diabetes screening
Doctors & NHSMedical businesses
Revvity has launched the GSP T1D 3plex kit. It aims to support population screening programmes for children at risk of developing type 1 diabetes months or years before symptoms emerge.
Why it matters
The launch is relevant to clinicians and diagnostic businesses following childhood screening technologies. The item describes the kit’s intended role but provides no performance data or regulatory status.
Protect your practice
Summary for general information only — not legal, clinical or insurance advice.